~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
Trilogy Tidings
November 2014
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
in this issue
Collaborative Consulting Works for Both Buyers and Sellers
Insurer Ratings: 2014
The Ultimate Guide to Opportunity Assessment
What does Trilogy do?
Resources from our Archives
     If you don't know about collaborative consulting, you should. Whether you're a buyer or seller of consulting services, this business model can pay handsome dividends. Read on ... 

Regards,
Joe

Collaborative Consulting Works for Both Buyers and Sellers       
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

     If you're a buyer of consulting services, think about the steps you take most often. First, you identify the kind of support you think you need, i.e. what's the problem to be solved? Second, if you know or have direct experience with a consultant in that space you will contact that individual or firm. Or, if you cannot identify such a resource, you take a third step: Get some recommendations or do some research to (a) identify individuals with the required expertise or specialization or (b) contact a large "name brand" consulting firm in which you assume the required expertise or specialization exists. I suggest you also consider another (c) option - collaborative consulting.


     I have operated Trilogy Associates as a collaborative consultancy for several decades. This business model works remarkably well for our clients, and it works equally well for individual consultants with whom I collaborate. So, what is this model?

 

     Collaborative consulting means, as a buyer of services, you make contact with an individual consultant known to collaborate with others offering complementary services to his/her own. Collaborative consultants are strongly networked with others with whom they have worked successfully, and developed mutual trust, for many years. The buyer (the client) gains the benefits of an ad hoc fit-for-purpose collaborative team of experienced consultants assembled in direct response to buyer needs. At least in my experience, clients get precisely the expertise they need in a cost- and time-efficient manner. They are generally happy with the outcome.

 

     You will find more detail about the benefits of collaborative consulting and the elements of competence that matter in my whitepaper: "The Power of Collaborative Consulting." Whether you are a buyer or seller of consulting services, you may find value in this proven successful business model. 

 

Insurer Ratings: 2014       
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

     How do providers rate the healthcare payers they deal with? You can find out in Medscape's Insurer Ratings Report. None of the insurers is uniformly loved -- no surprise there. But there's more in the report than just comparative ratings, which were offered by US-based physicians earlier this year. You will also discover some findings dealing with the ACA (Obamacare) and some differences reported by practice speciality. Not only is this useful information for patients, it can also support reimbursement initiatives undertaken by suppliers offering new technologies.

The Ultimate Guide to Opportunity Assessment       
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

     A recent new-product initiative reminded me of the intricate pathway to follow in assessing the market potential of a new entry. Every such pathway starts here:

  • Does it make sufficient clinical sense for the patient?
  • Does it make economic sense for the provider?

If affirmative answers to both questions are not forthcoming, nothing else matters. Your pathway has a dead-end.

 

What does Trilogy do? 
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
     Trilogy Associates facilitates business growth and renewal through commercialization of new products, providing the following services:
  • Opportunity assessment
  • Business planning and enterprise growth strategies
  • New-product conceptualization, commercialization and marketing
  • Market research and competitive assessment
  • Business development and partnering
  • Market and technological due diligence
  • Assessment of the therapeutic and diagnostic potential of novel technologies
  • Design of efficient and effective development strategies for early-stage biomedical products
  • Business and technical writing/publishing

     Inquiries to establish whether and how we might support your business initiatives are always welcome.  Contact us.

Resources from our Archives 
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
     Check out our Reading Room to view my published articles, presentations and white papers on a variety of topics.
  
     And, you can examine an archive of my prior newsletters (since February 2007).
Contact Information
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
Joseph J. Kalinowski, Principal
919.533.6285
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~